{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:50:16Z","timestamp":1782229816401,"version":"3.54.5"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.nec.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:14:05Z","timestamp":1775178845000},"page":"293-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuropathology of Intramedullary Spinal Cord Tumors"],"prefix":"10.1016","volume":"37","author":[{"given":"Jason","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.nec.2026.02.003_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.nec.2026.02.003_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1006418506213","article-title":"Pediatric intramedullary spinal cord tumors: special considerations","volume":"47","author":"Houten","year":"2000","journal-title":"J Neuro Oncol"},{"issue":"8","key":"10.1016\/j.nec.2026.02.003_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11912-022-01260-w","article-title":"Ependymoma: evaluation and management updates","volume":"24","author":"Ruda","year":"2022","journal-title":"Curr Oncol Rep"},{"issue":"6","key":"10.1016\/j.nec.2026.02.003_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.17116\/neiro201579622-28","article-title":"Comparative epidemiology of adult and pediatric intramedullary spinal cord tumors","volume":"79","author":"Kushel","year":"2015","journal-title":"Zh Vopr Neirokhir Im N N Burdenko"},{"issue":"4","key":"10.1016\/j.nec.2026.02.003_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13060","article-title":"The 2021 WHO classification of Tumors of the Central Nervous System: an update on pediatric low-grade gliomas and glioneuronal tumors","volume":"32","author":"Bale","year":"2022","journal-title":"Brain Pathol"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00401-018-1837-8","article-title":"Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A\/B and ATRX alterations","volume":"136","author":"Reinhardt","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.nec.2026.02.003_bib7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00401-019-02056-2","article-title":"MYCN amplification drives an aggressive form of spinal ependymoma","volume":"138","author":"Ghasemi","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"9","key":"10.1016\/j.nec.2026.02.003_bib8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/jnen\/nlz064","article-title":"Spinal cord Ependymomas with MYCN amplification show aggressive clinical behavior","volume":"78","author":"Swanson","year":"2019","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40478-020-00973-y","article-title":"High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma","volume":"8","author":"Raffeld","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00381-004-0973-8","article-title":"Primary spinal cord oligodendroglioma: case report and review of the literature","volume":"21","author":"Fountas","year":"2005","journal-title":"Childs Nerv Syst"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/bpa.12585","article-title":"CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue","volume":"28","author":"Yoshida","year":"2018","journal-title":"Brain Pathol"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib12","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","article-title":"Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups","volume":"27","author":"Pajtler","year":"2015","journal-title":"Cancer Cell"},{"issue":"Suppl 5","key":"10.1016\/j.nec.2026.02.003_bib13","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11060-016-2167-0","article-title":"Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes","volume":"129","author":"Bates","year":"2016","journal-title":"J Neuro Oncol"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-016-2218-6","article-title":"Primary spinal myxopapillary ependymoma in the pediatric population: a study from the surveillance, epidemiology, and end results (SEER) database","volume":"130","author":"Lucchesi","year":"2016","journal-title":"J Neuro Oncol"},{"issue":"3","key":"10.1016\/j.nec.2026.02.003_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11060-007-9411-6","article-title":"Subependymoma revisited: clinicopathological evaluation of 83 cases","volume":"85","author":"Rushing","year":"2007","journal-title":"J Neuro Oncol"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3340\/jkns.2017.0405.001","article-title":"Spinal cord subependymoma surgery : a multi-institutional experience","volume":"61","author":"Yuh","year":"2018","journal-title":"J Korean Neurosurg Soc"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3171\/2010.3.SPINE09430","article-title":"Clinical presentation, histology, and treatment in 430 patients with primary tumors of the spinal cord, spinal meninges, or cauda equina","volume":"13","author":"Engelhard","year":"2010","journal-title":"J Neurosurg Spine"},{"issue":"3","key":"10.1016\/j.nec.2026.02.003_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11060-016-2135-8","article-title":"Spinal cord ependymoma: a review of the literature and case series of ten patients","volume":"128","author":"Celano","year":"2016","journal-title":"J Neuro Oncol"},{"issue":"4","key":"10.1016\/j.nec.2026.02.003_bib20","first-page":"304","article-title":"Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity","volume":"10","author":"Prayson","year":"1997","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.nec.2026.02.003_bib21","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/neuonc\/noy118","article-title":"DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment","volume":"20","author":"Witt","year":"2018","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-019-02090-0","article-title":"Molecular characterization of histopathological ependymoma variants","volume":"139","author":"Neumann","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"9679","key":"10.1016\/j.nec.2026.02.003_bib23","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","article-title":"Neurofibromatosis type 2","volume":"373","author":"Asthagiri","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.nec.2026.02.003_bib24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3171\/2010.11.SPINE10350","article-title":"Spinal ependymomas in neurofibromatosis type 2: a retrospective analysis of 55 patients","volume":"14","author":"Plotkin","year":"2011","journal-title":"J Neurosurg Spine"},{"issue":"4","key":"10.1016\/j.nec.2026.02.003_bib25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-019-02029-5","article-title":"An update on the CNS manifestations of neurofibromatosis type 2","volume":"139","author":"Coy","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0002-9440(10)65158-9","article-title":"Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas","volume":"155","author":"Ebert","year":"1999","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.nec.2026.02.003_bib27","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00381-012-1908-4","article-title":"Spinal cord ependymomas in children and adolescents","volume":"28","author":"Benesch","year":"2012","journal-title":"Childs Nerv Syst"},{"issue":"10","key":"10.1016\/j.nec.2026.02.003_bib28","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.jocn.2012.12.010","article-title":"Spinal ependymomas: benefits of extent of resection for different histological grades","volume":"20","author":"Oh","year":"2013","journal-title":"J Clin Neurosci"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1227\/NEU.0b013e3182004c1e","article-title":"Surgery for spinal cord ependymomas: outcome and prognostic factors","volume":"68","author":"Bostrom","year":"2011","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11060-015-1955-2","article-title":"Myxopapillary ependymomas in children: imaging, treatment and outcomes","volume":"126","author":"Bandopadhayay","year":"2016","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.nec.2026.02.003_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-5751-10-7","article-title":"Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts","volume":"10","author":"Ellison","year":"2011","journal-title":"J Negat Results Biomed"},{"issue":"4","key":"10.1016\/j.nec.2026.02.003_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","article-title":"Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas","volume":"37","author":"Ryall","year":"2020","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.nec.2026.02.003_bib33","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ng.2611","article-title":"Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas","volume":"45","author":"Zhang","year":"2013","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.nec.2026.02.003_bib34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ng.2682","article-title":"Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma","volume":"45","author":"Jones","year":"2013","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.nec.2026.02.003_bib35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00401-018-1898-8","article-title":"Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas","volume":"136","author":"Valera","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.nec.2026.02.003_bib36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1101\/gr.142604.112","article-title":"Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma","volume":"23","author":"Gutmann","year":"2013","journal-title":"Genome Res"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3171\/2015.9.PEDS15449","article-title":"Low rates of recurrence and slow progression of pediatric pilocytic astrocytoma after gross-total resection: justification for reducing surveillance imaging","volume":"17","author":"Dodgshun","year":"2016","journal-title":"J Neurosurg Pediatr"},{"issue":"3","key":"10.1016\/j.nec.2026.02.003_bib38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/02688697.2018.1549315","article-title":"Extent of resection predicts risk of progression in adult pilocytic astrocytoma","volume":"33","author":"Nelson","year":"2019","journal-title":"Br J Neurosurg"},{"issue":"6","key":"10.1016\/j.nec.2026.02.003_bib39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00401-016-1539-z","article-title":"Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology","volume":"131","author":"Qaddoumi","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00401-018-1865-4","article-title":"Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features","volume":"136","author":"Deng","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-017-1728-4","article-title":"Low-grade spinal glioneuronal tumors with BRAF gene fusion and 1p deletion but without leptomeningeal dissemination","volume":"134","author":"Chiang","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00401-025-02924-0","article-title":"Diffuse leptomeningeal glioneuronal tumor (DLGNT): a comprehensive clinical and molecular analysis","volume":"150","author":"Mikkelsen","year":"2025","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11060-016-2109-x","article-title":"Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation","volume":"128","author":"Dodgshun","year":"2016","journal-title":"J Neuro Oncol"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00401-018-1940-x","article-title":"Chromosome arm 1q gain is an adverse prognostic factor in localized and diffuse leptomeningeal glioneuronal tumors with BRAF gene fusion and 1p deletion","volume":"137","author":"Chiang","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib45","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00401-012-1037-x","article-title":"Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entity","volume":"124","author":"Rodriguez","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/BF00294510","article-title":"Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases","volume":"88","author":"Wolf","year":"1994","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.nec.2026.02.003_bib47","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3171\/jns.1993.79.6.0867","article-title":"Central nervous system gangliogliomas. Part 2: clinical outcome","volume":"79","author":"Lang","year":"1993","journal-title":"J Neurosurg"},{"key":"10.1016\/j.nec.2026.02.003_bib48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2051-5960-2-18","article-title":"Posterior fossa and spinal gangliogliomas form two distinct clinicopathologic and molecular subgroups","volume":"2","author":"Gupta","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.nec.2026.02.003_bib49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.humpath.2015.09.041","article-title":"Intramedullary gangliogliomas: histopathologic and molecular features of 25 cases","volume":"49","author":"Gessi","year":"2016","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.nec.2026.02.003_bib50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jnen\/61.7.575","article-title":"Gangliogliomas: an intriguing tumor entity associated with focal epilepsies","volume":"61","author":"Blumcke","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib51","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/(SICI)1097-0142(19970301)79:5<989::AID-CNCR16>3.0.CO;2-Z","article-title":"Ganglioglioma: an ultrastructural and immunohistochemical study","volume":"79","author":"Hirose","year":"1997","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.nec.2026.02.003_bib52","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00401-013-1100-2","article-title":"Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells","volume":"125","author":"Koelsche","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40478-018-0551-z","article-title":"The genetic landscape of ganglioglioma","volume":"6","author":"Pekmezci","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/bpa.12473","article-title":"Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma","volume":"28","author":"Pages","year":"2018","journal-title":"Brain Pathol"},{"issue":"6","key":"10.1016\/j.nec.2026.02.003_bib55","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/bpa.12455","article-title":"H3 K27M mutation in gangliogliomas can be associated with poor prognosis","volume":"27","author":"Kleinschmidt-DeMasters","year":"2017","journal-title":"Brain Pathol"},{"issue":"3","key":"10.1016\/j.nec.2026.02.003_bib56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/neuonc\/not169","article-title":"Clinical and prognostic features of adult patients with gangliogliomas","volume":"16","author":"Yust-Katz","year":"2014","journal-title":"Neuro Oncol"},{"issue":"25","key":"10.1016\/j.nec.2026.02.003_bib57","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1200\/JCO.2016.71.8726","article-title":"Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas","volume":"35","author":"Lassaletta","year":"2017","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.nec.2026.02.003_bib58","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/neuonc\/noaa077","article-title":"Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas","volume":"22","author":"Fukuoka","year":"2020","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40478-020-00913-w","article-title":"The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation","volume":"8","author":"Chai","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"10.1016\/j.nec.2026.02.003_bib60","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00401-015-1463-7","article-title":"High frequency of H3F3A (K27M) mutations characterizes pediatric and adult high-grade gliomas of the spinal cord","volume":"130","author":"Gessi","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib61","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/bpa.12336","article-title":"Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations","volume":"26","author":"Solomon","year":"2016","journal-title":"Brain Pathol"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib62","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","article-title":"Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas","volume":"24","author":"Bender","year":"2013","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib63","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00401-014-1338-3","article-title":"A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas","volume":"128","author":"Venneti","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib64","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41467-019-09981-6","article-title":"PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism","volume":"10","author":"Jain","year":"2019","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib65","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib66","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ng.2950","article-title":"Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma","volume":"46","author":"Fontebasso","year":"2014","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib67","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"Wu","year":"2014","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib68","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","article-title":"Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma","volume":"46","author":"Taylor","year":"2014","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.nec.2026.02.003_bib69","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.nec.2026.02.003_bib70","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00401-020-02142-w","article-title":"Histone H3 wild-type DIPG\/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation","volume":"139","author":"Castel","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s40478-018-0614-1","article-title":"Transcriptomic and epigenetic profiling of \u2019diffuse midline gliomas, H3 K27M-mutant\u2019 discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location","volume":"6","author":"Castel","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"10.1016\/j.nec.2026.02.003_bib72","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00401-020-02155-5","article-title":"Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition","volume":"139","author":"Mondal","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib73","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/neuonc\/noaa251","article-title":"A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR","volume":"23","author":"Sievers","year":"2021","journal-title":"Neuro Oncol"},{"issue":"19","key":"10.1016\/j.nec.2026.02.003_bib74","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","article-title":"Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the international and European society for pediatric oncology DIPG registries","volume":"36","author":"Hoffman","year":"2018","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.nec.2026.02.003_bib75","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1158\/1078-0432.CCR-19-0126","article-title":"TP53 pathway alterations drive radioresistance in diffuse intrinsic pontine gliomas (DIPG)","volume":"25","author":"Werbrouck","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib76","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/nan.12593","article-title":"Spinal cord astroblastoma with an EWSR1-BEND2 fusion classified as a high-grade neuroepithelial tumour with MN1 alteration","volume":"46","author":"Yamasaki","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"10.1016\/j.nec.2026.02.003_bib77","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10014-020-00372-0","article-title":"Central nervous system neuroepithelial tumors with MN1-alteration: an individual patient data meta-analysis of 73 cases","volume":"37","author":"Chen","year":"2020","journal-title":"Brain Tumor Pathol"},{"issue":"3","key":"10.1016\/j.nec.2026.02.003_bib78","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1750-3639.2000.tb00266.x","article-title":"Astroblastoma: clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization","volume":"10","author":"Brat","year":"2000","journal-title":"Brain Pathol"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib79","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","article-title":"New brain tumor entities emerge from molecular classification of CNS-PNETs","volume":"164","author":"Sturm","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib80","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bpa.12561","article-title":"Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities","volume":"28","author":"Wood","year":"2018","journal-title":"Brain Pathol"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib81","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bpa.12565","article-title":"Astroblastoma: a distinct tumor entity characterized by alterations of the X chromosome and MN1 rearrangement","volume":"28","author":"Hirose","year":"2018","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib82","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40478-019-0689-3","article-title":"Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis","volume":"7","author":"Lehman","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib83","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s40478-019-0834-z","article-title":"Pediatric methylation class HGNET-MN1: unresolved issues with terminology and grading","volume":"7","author":"Tauziede-Espariat","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib84","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/nan.12610","article-title":"Brain tumour diagnostics using a DNA methylation-based classifier as a diagnostic support tool","volume":"46","author":"Priesterbach-Ackley","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib85","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40478-019-0668-8","article-title":"Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre","volume":"7","author":"Jaunmuktane","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"7697","key":"10.1016\/j.nec.2026.02.003_bib86","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S2352-4642(19)30342-6","article-title":"DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study","volume":"4","author":"Pickles","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib88","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00401-019-02088-8","article-title":"The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population","volume":"139","author":"Gareton","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.nec.2026.02.003_bib89","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/jcvjs.JCVJS_1_17","article-title":"A very rare spinal cord tumor primary spinal oligodendroglioma: a review of sixty cases in the literature","volume":"8","author":"Hasturk","year":"2017","journal-title":"J Craniovertebr Junction Spine"},{"issue":"3","key":"10.1016\/j.nec.2026.02.003_bib90","first-page":"241","article-title":"Spinal gliosarcoma: a light, immunohistochemical and ultrastructural study","volume":"25","author":"Carstens","year":"1995","journal-title":"Ann Clin Lab Sci"},{"issue":"3","key":"10.1016\/j.nec.2026.02.003_bib91","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejca.2011.09.005","article-title":"Central nervous system atypical teratoid rhabdoid tumours: the Canadian paediatric brain tumour consortium experience","volume":"48","author":"Lafay-Cousin","year":"2012","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.nec.2026.02.003_bib92","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/bpa.12747","article-title":"High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis","volume":"30","author":"Ferris","year":"2020","journal-title":"Brain Pathol"},{"issue":"2","key":"10.1016\/j.nec.2026.02.003_bib93","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-013-1228-0","article-title":"Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity","volume":"128","author":"Korshunov","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.nec.2026.02.003_bib94","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/PAS.0b013e3182196a39","article-title":"Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid\/rhabdoid tumor showing retained SMARCB1 (INI1) expression","volume":"35","author":"Hasselblatt","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.nec.2026.02.003_bib95","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/neuonc\/noz235","article-title":"Molecular subgrouping of atypical teratoid\/rhabdoid tumors-a reinvestigation and current consensus","volume":"22","author":"Ho","year":"2020","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.nec.2026.02.003_bib96","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccell.2016.02.001","article-title":"Atypical teratoid\/Rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes","volume":"29","author":"Johann","year":"2016","journal-title":"Cancer Cell"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368026000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368026000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:34:10Z","timestamp":1782228850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368026000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1042368026000045"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2026.02.003","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropathology of Intramedullary Spinal Cord Tumors","name":"articletitle","label":"Article Title"},{"value":"Neurosurgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nec.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}